| 1 |
ODC1
| [3] Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways | D07883
D07883
|
Eflornithine
| [1] 65 65 |
| 2 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D00729
D00729
|
Loperamide
| [2] 13 13, 97 |
| 3 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D00843
D00843
|
Nalbuphine
| [1] 85 85 |
| 4 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D01340
D01340
|
Naloxone
| [2] 6 6, 226 |
| 5 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D02095
D02095
|
Naltrexone
| [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
| 6 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D03783
D03783
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 7 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05111
D05111
|
Nalmefene
| [1] 6 6 |
| 8 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05113
D05113
|
Naltrexone
| [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
| 9 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05312
D05312
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 10 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05462
D05462
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 11 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D07113
D07113
|
Loperamide
| [2] 13 13, 97 |
| 12 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D08144
D08144
|
Loperamide
| [2] 13 13, 97 |
| 13 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D08246
D08246
|
Nalbuphine
| [1] 85 85 |
| 14 |
OPRD1
| [3] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D08249
D08249
|
Naloxone
| [2] 6 6, 226 |
| 15 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00729
D00729
|
Loperamide
| [2] 13 13, 97 |
| 16 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00836
D00836
|
Buprenorphine
| [3] 46 46, 70, 298 |
| 17 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00843
D00843
|
Nalbuphine
| [1] 85 85 |
| 18 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01340
D01340
|
Naloxone
| [2] 6 6, 226 |
| 19 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D02095
D02095
|
Naltrexone
| [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
| 20 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D03783
D03783
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 21 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D05111
D05111
|
Nalmefene
| [1] 6 6 |
| 22 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D05113
D05113
|
Naltrexone
| [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
| 23 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D05312
D05312
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 24 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D05462
D05462
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 25 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D07113
D07113
|
Loperamide
| [2] 13 13, 97 |
| 26 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D07132
D07132
|
Buprenorphine
| [3] 46 46, 70, 298 |
| 27 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D08144
D08144
|
Loperamide
| [2] 13 13, 97 |
| 28 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D08246
D08246
|
Nalbuphine
| [1] 85 85 |
| 29 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D08249
D08249
|
Naloxone
| [2] 6 6, 226 |
| 30 |
OPRK1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D08639
D08639
|
Trimebutine
| [1] 51 51 |
| 31 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D00320
D00320
|
Fentanyl
| [4] 46 46, 70, 215, 231 |
| 32 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D00729
D00729
|
Loperamide
| [2] 13 13, 97 |
| 33 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D00836
D00836
|
Buprenorphine
| [3] 46 46, 70, 298 |
| 34 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D00839
D00839
|
Hydromorphone
| [1] 70 70 |
| 35 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D00842
D00842
|
Morphine
| [6] 36 36, 46, 70, 85, 86, 298 |
| 36 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D00843
D00843
|
Nalbuphine
| [1] 85 85 |
| 37 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D00845
D00845
|
Sufentanil
| [2] 70 70, 280 |
| 38 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D01177
D01177
|
Remifentanil
| [2] 6 6, 70 |
| 39 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D01340
D01340
|
Naloxone
| [2] 6 6, 226 |
| 40 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D01355
D01355
|
Tramadol
| [5] 46 46, 70, 78, 226, 271 |
| 41 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D01383
D01383
|
Meperidine
| [1] 298 298 |
| 42 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D01399
D01399
|
Fentanyl
| [4] 46 46, 70, 215, 231 |
| 43 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D01481
D01481
|
Dihydrocodeine
| [1] 310 310 |
| 44 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D02095
D02095
|
Naltrexone
| [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
| 45 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D02271
D02271
|
Morphine
| [6] 36 36, 46, 70, 85, 86, 298 |
| 46 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D03783
D03783
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 47 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D05111
D05111
|
Nalmefene
| [1] 6 6 |
| 48 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D05113
D05113
|
Naltrexone
| [13] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
| 49 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D05312
D05312
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 50 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D05462
D05462
|
Oxycodone
| [7] 6 6, 13, 46, 70, 226, 231, 298 |
| 51 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D05938
D05938
|
Sufentanil
| [2] 70 70, 280 |
| 52 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D07113
D07113
|
Loperamide
| [2] 13 13, 97 |
| 53 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D07132
D07132
|
Buprenorphine
| [3] 46 46, 70, 298 |
| 54 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D07831
D07831
|
Dihydrocodeine
| [1] 310 310 |
| 55 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08047
D08047
|
Hydromorphone
| [1] 70 70 |
| 56 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08144
D08144
|
Loperamide
| [2] 13 13, 97 |
| 57 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08233
D08233
|
Morphine
| [6] 36 36, 46, 70, 85, 86, 298 |
| 58 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08246
D08246
|
Nalbuphine
| [1] 85 85 |
| 59 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08249
D08249
|
Naloxone
| [2] 6 6, 226 |
| 60 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08323
D08323
|
Oxymorphone
| [1] 70 70 |
| 61 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08343
D08343
|
Meperidine
| [1] 298 298 |
| 62 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08473
D08473
|
Remifentanil
| [2] 6 6, 70 |
| 63 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08623
D08623
|
Tramadol
| [5] 46 46, 70, 78, 226, 271 |
| 64 |
OPRM1
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | D08639
D08639
|
Trimebutine
| [1] 51 51 |
| 65 |
OXTR
| [4] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway | D00089
D00089
|
Oxytocin
| [6] 6 6, 72, 127, 193, 206, 226 |
| 66 |
OXTR
| [4] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway | D03008
D03008
|
Atosiban
| [1] 118 118 |
| 67 |
OXTR
| [4] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway | D07229
D07229
|
Carbetocin
| [1] 193 193 |